In 1972 Rapamycin was discovered on Easter Island. Isolated from exotic bacterium by researchers, it was originally used as an anti-fungal ointment. Over the years a wide range of uses has been found for the medication. Rapamycin has become well used by doctors in a variety of fields for its anti-proliferative properties, helping the body survive and thrive after a variety of surgical procedures. When stents are inserted in a procedure to widen clogged blood vessels, Rapamycin is used to coat them so as to prevent the vessel from narrowing again. When organ-transfer is needed for Hemolytic-Uremic syndrome, a rare kidney disease, Rapamycin minimizes the chance of the disease spreading to the new organ. Perhaps most phenomenally, Rapamycin has been noted to helps shrink cancer tumors by stimulating the body’s immune system. This attracted the attention of Dr. Mihail Blagosklonny, Professor of Oncology at the Rosewell Park Cancer Institute in Buffalo, New York, to conduct experiments using Rapamycin to not only use the drug for cancer but also for a wide range of illnesses that have been almost unaffected by modern medicine.
Blagoskonny proceeded to conduct innovative experiments on lab mice. He found that when confronted with a fatal dose of Tuberculosis, that the lab mice were more likely to recover when given Rapamycin. Other effects were noted as a well. Mice treated with Rapamycin soon found their ability to grasp improve, with their heart health receiving a notable boost. Mice experienced recovery of mental faculties when treating with the drug, as well as protecting against future brain issues. Blagoskonny concluded that research into using these effects to cure and treat. Muscular Dystrophy and Alexheimers would be probable, and further suggested ways that the drug could be used to treat the degenerative disease Lupus. The potential for Rapamycin astounded him even more than the myriad of uses it had already
Mikhail Blagosklonny possesses a strong belief that there is a link between Rapamycin and long-life due to these and many of other gains that Rapamycin provides in medicine. Primarily an Oncologist, he has written on the possible link between cancer treatments and long life and has sought treatments that both eliminate cancerous cells and do so without painful chemical or intrusive surgery. With the treatment of the world’s most devastating diseases being possible by Rapamycin, he believes the drug can increase life-span in human beings, with an aim to make the necessary procedures available to everyone. Not just the rich should be able to afford long life and good health but all human beings should share optimal health at a low price. Rapamycin, with its multiple uses and cost-effectiveness compared to other procedures, is shaping to be that treatment. And the gains Blagosklonny has hoped for may just be rooted in all that Rapamycin can do already.